These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 14555559)

  • 1. Increase in thrombomodulin concentrations after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension.
    Sakamaki F; Kyotani S; Nagaya N; Sato N; Oya H; Nakanishi N
    Chest; 2003 Oct; 124(4):1305-11. PubMed ID: 14555559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of high density lipoprotein cholesterol and outcomes in chronic thromboembolic pulmonary hypertension.
    Khirfan G; Tejwani V; Wang X; Li M; DiDonato J; Dweik RA; Smedira N; Heresi GA
    PLoS One; 2018; 13(5):e0197700. PubMed ID: 29813091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentraxin3 in chronic thromboembolic pulmonary hypertension: a new biomarker for screening from remitted pulmonary thromboembolism.
    Naito A; Tanabe N; Jujo T; Shigeta A; Sugiura T; Sakao S; Ishida K; Tatsumi K
    PLoS One; 2014; 9(11):e113086. PubMed ID: 25412085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pre- and postoperative assessment of hemodynamics in patients with chronic thromboembolic pulmonary hypertension by MR techniques].
    Ley S; Kramm T; Kauczor HU; Mayer E; Heussel CP; Thelen M; Kreitner KF
    Rofo; 2003 Dec; 175(12):1647-54. PubMed ID: 14661135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative partitioning of pulmonary vascular resistance correlates with early outcome after thromboendarterectomy for chronic thromboembolic pulmonary hypertension.
    Kim NH; Fesler P; Channick RN; Knowlton KU; Ben-Yehuda O; Lee SH; Naeije R; Rubin LJ
    Circulation; 2004 Jan; 109(1):18-22. PubMed ID: 14699009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy.
    Sakamaki F; Kyotani S; Nagaya N; Sato N; Oya H; Satoh T; Nakanishi N
    Circulation; 2000 Nov; 102(22):2720-5. PubMed ID: 11094038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension.
    Nagaya N; Sasaki N; Ando M; Ogino H; Sakamaki F; Kyotani S; Nakanishi N
    Chest; 2003 Feb; 123(2):338-43. PubMed ID: 12576349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased time constant of the pulmonary circulation in chronic thromboembolic pulmonary hypertension.
    MacKenzie Ross RV; Toshner MR; Soon E; Naeije R; Pepke-Zaba J
    Am J Physiol Heart Circ Physiol; 2013 Jul; 305(2):H259-64. PubMed ID: 23686712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of right ventricular Tei index in the noninvasive evaluation of chronic thromboembolic pulmonary hypertension before and after pulmonary thromboendarterectomy.
    Blanchard DG; Malouf PJ; Gurudevan SV; Auger WR; Madani MM; Thistlethwaite P; Waltman TJ; Daniels LB; Raisinghani AB; DeMaria AN
    JACC Cardiovasc Imaging; 2009 Feb; 2(2):143-9. PubMed ID: 19356547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of impaired right and left ventricular function in chronic embolic pulmonary hypertension: changes after pulmonary thromboendarterectomy.
    Menzel T; Wagner S; Kramm T; Mohr-Kahaly S; Mayer E; Braeuninger S; Meyer J
    Chest; 2000 Oct; 118(4):897-903. PubMed ID: 11035654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic thromboembolic pulmonary hypertension: pre- and postoperative assessment with breath-hold MR imaging techniques.
    Kreitner KF; Ley S; Kauczor HU; Mayer E; Kramm T; Pitton MB; Krummenauer F; Thelen M
    Radiology; 2004 Aug; 232(2):535-43. PubMed ID: 15215554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of thrombomodulin in pulmonary hypertension.
    Cacoub P; Karmochkine M; Dorent R; Nataf P; Piette JC; Godeau P; Gandjbakhch I; Boffa MC
    Am J Med; 1996 Aug; 101(2):160-4. PubMed ID: 8757355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical Treatment of Chronic Thromboembolic Pulmonary Hypertension: Pulmonary Thromboendarterectomy.
    Madani MM
    Methodist Debakey Cardiovasc J; 2016; 12(4):213-218. PubMed ID: 28289496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension: A Possible Novel Therapeutic Target.
    Satoh T; Satoh K; Yaoita N; Kikuchi N; Omura J; Kurosawa R; Numano K; Al-Mamun E; Siddique MA; Sunamura S; Nogi M; Suzuki K; Miyata S; Morser J; Shimokawa H
    Circ Res; 2017 Apr; 120(8):1246-1262. PubMed ID: 28289017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and clinical correlates of endothelin-1 in chronic thromboembolic pulmonary hypertension.
    Reesink HJ; Meijer RC; Lutter R; Boomsma F; Jansen HM; Kloek JJ; Bresser P
    Circ J; 2006 Aug; 70(8):1058-63. PubMed ID: 16864942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of fractional pulse pressure on the outcome of pulmonary thromboendarterectomy.
    Tanabe N; Okada O; Abe Y; Masuda M; Nakajima N; Kuriyama T
    Eur Respir J; 2001 Apr; 17(4):653-9. PubMed ID: 11401060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin-Activatable Fibrinolysis Inhibitor in Chronic Thromboembolic Pulmonary Hypertension.
    Yaoita N; Satoh K; Satoh T; Sugimura K; Tatebe S; Yamamoto S; Aoki T; Miura M; Miyata S; Kawamura T; Horiuchi H; Fukumoto Y; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1293-301. PubMed ID: 27102961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboendarterectomy for severe chronic thromboembolic pulmonary hypertension.
    Ishida K; Masuda M
    Asian Cardiovasc Thorac Ann; 2007 Jun; 15(3):229-33. PubMed ID: 17540993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial cells from pulmonary endarterectomy specimens possess a high angiogenic potential and express high levels of hepatocyte growth factor.
    Naito A; Sakao S; Lang IM; Voelkel NF; Jujo T; Ishida K; Sugiura T; Matsumiya G; Yoshino I; Tanabe N; Tatsumi K
    BMC Pulm Med; 2018 Dec; 18(1):197. PubMed ID: 30594174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy-associated plasma protein A - a new indicator of pulmonary vascular remodeling in chronic thromboembolic pulmonary hypertension?
    Kriechbaum SD; Rudolph F; Wiedenroth CB; Mielzarek L; Haas M; Guth S; Hamm CW; Mayer E; Liebetrau C; Keller T
    Respir Res; 2020 Aug; 21(1):204. PubMed ID: 32746916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.